We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avalo Therapeutics Inc | NASDAQ:AVTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.43 | 2.99% | 14.79 | 14.79 | 16.48 | 176 | 12:40:09 |
CUSIP No. 05338F108
|
|
(1) Names of reporting persons Point72 Asset Management, L.P.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 6,008,850 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 6,008,850 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
6,008,850 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 5.3% (see Item 4)
|
|
(12) Type of reporting person (see instructions) PN
|
CUSIP No. 05338F108
|
|
(1) Names of reporting persons Point72 Capital Advisors, Inc.
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Delaware
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 6,008,850 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 6,008,850 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
6,008,850 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 5.3% (see Item 4)
|
|
(12) Type of reporting person (see instructions) CO
|
CUSIP No. 05338F108
|
|
(1) Names of reporting persons Point72 Hong Kong Limited
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization Hong Kong
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 3,826 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 3,826 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
3,826 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) <0.1% (see Item 4)
|
|
(12) Type of reporting person (see instructions) OO
|
CUSIP No. 05338F108
|
|
(1) Names of reporting persons Steven A. Cohen
|
|
(2) Check the appropriate box if a member of a group
|
(a)
|
(see instructions)
|
(b)X
|
(3) SEC use only
|
|
(4) Citizenship or place of organization United States
|
|
Number of shares beneficially owned by each reporting person with:
|
|
(5) Sole voting power 0
|
|
(6) Shared voting power 6,012,676 (see Item 4)
|
|
(7) Sole dispositive power 0
|
|
(8) Shared dispositive power 6,012,676 (see Item 4)
|
|
(9) Aggregate amount beneficially owned by each reporting person
6,012,676 (see Item 4)
|
|
(10) Check if the aggregate amount in Row (9) excludes certain shares
(see instructions)
|
|
(11) Percent of class represented by amount in Row (9) 5.4% (see Item 4)
|
|
(12) Type of reporting person (see instructions) IN
|
1 Year Avalo Therapeutics Chart |
1 Month Avalo Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions